Since the PI3K/AKT/mTOR pathway is overactivated in over 90% of HNSCC, through various mechanisms, it is a highly interesting pathway to target in HNSCC, especially combined with ICIs [60]. The gene discussed is AKT1; the disease is head and neck squamous cell carcinoma.